UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000044115
Receipt number R000050367
Scientific Title Observation study of continuous glucose monitoring for postoperative patients in esophageal cancer
Date of disclosure of the study information 2021/05/06
Last modified on 2023/12/06 09:41:10

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Observation study of continuous glucose monitoring for postoperative patients in esophageal cancer

Acronym

The continuous glucose monitoring for postoperative patients in esophageal cancer

Scientific Title

Observation study of continuous glucose monitoring for postoperative patients in esophageal cancer

Scientific Title:Acronym

The continuous glucose monitoring for postoperative patients in esophageal cancer

Region

Japan


Condition

Condition

Esophageal cancer

Classification by specialty

Gastrointestinal surgery Endocrine surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To investigate postoperative changes in blood glucose levels in patients who have undergone radical surgery for esophageal cancer

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

14-day continuous glucose monitoring

Key secondary outcomes

5-day dietary and symptom recording


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

75 years-old >=

Gender

Male and Female

Key inclusion criteria

1) Histologically diagnosed as esophageal cancer.
2) Radical resection has been performed.
3) The surgical procedure (thoracotomy, thoracoscope, robot-assisted surgery, etc.) does not matter.
4) More than 3 months have passed since the esophagectomy, and the weight loss has subsided by oral intakes.
5) Stage I-IVA (resectable).
6) The age at the time of registration.
7) Gender does not matter.
8) PS: ECOG performance status score 0-1.
9) Patients who fill out the survey form.
10) Written consent has been obtained from the patient for participation in the study.

Key exclusion criteria

1) Patients who had not radical surgery.
2) Salvage surgery case.
3) During the other anti-cancer treatment (chemotherapy, radiation therapy, etc.).
4) Diabetes is being treated with oral hypoglycemic agents and insulin (perioperative insulin administration is acceptable).
5) Enteral nutritional supplements and other dietary supplements are also used.
6) There are some pathological conditions that the investigator deems inappropriate.

Target sample size

20


Research contact person

Name of lead principal investigator

1st name Naoki
Middle name
Last name Hiki

Organization

Kitasato University School of Medicine

Division name

Department of Upper Gastrointestinal Surgery

Zip code

252-0374

Address

Kitasato 1-15-1, Minami-ku, Sagamihara, Kanagawa, Japan

TEL

042-778-8111

Email

mniihara@med.kitasato-u.ac.jp


Public contact

Name of contact person

1st name Masahiro
Middle name
Last name Niihara

Organization

Kitasato University School of Medicine

Division name

Department of Upper Gastrointestinal Surgery

Zip code

252-0374

Address

Kitasato 1-15-1, Minami-ku, Sagamihara, Kanagawa, Japan

TEL

042-778-8111

Homepage URL


Email

mniihara@med.kitasato-u.ac.jp


Sponsor or person

Institute

Kitasato University Hospital

Institute

Department

Personal name



Funding Source

Organization

Kitasato University Hospital

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kitasato University School of Medicine Clinical Research Ethics Committee

Address

Kitasato 1-15-1, Minami-ku, Sagamihara, Kanagawa, Japan

Tel

042-778-8273

Email

rinrib@med.kitasato-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2021 Year 05 Month 06 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2020 Year 11 Month 05 Day

Date of IRB

2020 Year 11 Month 18 Day

Anticipated trial start date

2021 Year 04 Month 01 Day

Last follow-up date

2022 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

None


Management information

Registered date

2021 Year 05 Month 06 Day

Last modified on

2023 Year 12 Month 06 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000050367


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name